Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1900)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
728
Price
$568.78
Total Value
$414.07K
Shares Held After
41,300
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,339
Price
$567.76
Total Value
$760.23K
Shares Held After
42,028
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,261
Price
$566.72
Total Value
$714.63K
Shares Held After
43,367
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$565.69
Total Value
$318.49K
Shares Held After
44,628
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,369
Price
$564.59
Total Value
$772.92K
Shares Held After
45,191
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,638
Price
$563.68
Total Value
$923.31K
Shares Held After
46,560
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$562.59
Total Value
$855.13K
Shares Held After
48,198
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
295
Price
$561.53
Total Value
$165.65K
Shares Held After
49,718
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
228
Price
$571.48
Total Value
$130.30K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
332
Price
$570.50
Total Value
$189.40K
Shares Held After
19,104
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
844
Price
$568.90
Total Value
$480.15K
Shares Held After
19,436
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,605
Price
$567.91
Total Value
$911.50K
Shares Held After
20,280
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
934
Price
$566.87
Total Value
$529.45K
Shares Held After
21,885
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
893
Price
$566.00
Total Value
$505.43K
Shares Held After
22,819
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,208
Price
$564.82
Total Value
$682.30K
Shares Held After
23,712
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,675
Price
$563.87
Total Value
$944.49K
Shares Held After
24,920
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,961
Price
$562.77
Total Value
$1.10M
Shares Held After
26,595
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$561.48
Total Value
$179.67K
Shares Held After
28,556
% of Holdings
1.1%
electroCore, Inc. (ECOR)
Lev Joshua S. — CFO and Interim President
Shares
6,667
Price
$9.00
Total Value
$60.00K
Shares Held After
84,889
% of Holdings
7.3%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
148
Price
$32.67
Total Value
$4.84K
Shares Held After
833,694
% of Holdings
0.0%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
119,852
Price
$31.88
Total Value
$3.82M
Shares Held After
833,842
% of Holdings
12.6%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
30,000
Price
$9.00
Total Value
$270.00K
Shares Held After
895,559
% of Holdings
3.2%
908 Devices Inc. (MASS)
Griffith Joseph H. IV — Chief Financial Officer
Shares
6,940
Price
$9.03
Total Value
$62.67K
Shares Held After
132,956
% of Holdings
5.0%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,989
Price
$4.93
Total Value
$14.74K
Shares Held After
182,161
% of Holdings
1.6%
QTREX Quantum Ltd. (QTEX)
Tehila Yafit — Chief Financial Officer
Shares
15,000
Price
$3.00
Total Value
$45.00K
Shares Held After
900,000
% of Holdings
1.6%
QTREX Quantum Ltd. (QTEX)
Tehila Yafit — Chief Financial Officer
Shares
15,000
Price
$2.56
Total Value
$38.40K
Shares Held After
915,000
% of Holdings
1.6%
MYOMO, INC. (MYO)
Kovelman Harry — Chief Medical Officer
Shares
11,536
Price
$1.02
Total Value
$11.73K
Shares Held After
108,618
% of Holdings
9.6%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
JW Asset Management, LLC — See footnote 3
Shares
65,100
Price
$72.89
Total Value
$4.75M
Shares Held After
2,890,582
% of Holdings
2.2%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
48,000
Price
$5.59
Total Value
$268.32K
Shares Held After
3,175,476
% of Holdings
1.5%
Nakamoto Inc. (NAKA)
Bailey David F — Director
Shares
7,115
Price
$5.79
Total Value
$41.20K
Shares Held After
3,127,476
% of Holdings
0.2%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Wai Conrad — CEO, Counterpart Health
Shares
220,426
Price
$3.99
Total Value
$879.50K
Shares Held After
1,390,056
% of Holdings
13.7%
TREACE MEDICAL CONCEPTS, INC. (TMCI)
Treace John T. — Director
Shares
61,202
Price
$3.02
Total Value
$184.82K
Shares Held After
7,273,833
% of Holdings
0.8%
Cencora, Inc. (COR)
DURCAN DERMOT MARK — Director
Shares
4,000
Price
$266.26
Total Value
$1.07M
Shares Held After
27,767
% of Holdings
14.4%
PACIFIC HEALTH CARE ORGANIZATION INC (PFHO)
KUBOTA TOM — Director
Shares
65,258
Price
$1.00
Total Value
$65.26K
Shares Held After
8,475,258
% of Holdings
0.8%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
NEXGEL, INC. (NXGL)
Levy Adam R. — Director
Shares
3,000
Price
$0.60
Total Value
$1.79K
Shares Held After
354,692
% of Holdings
0.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,852
Price
$0.48
Total Value
$38.81K
Shares Held After
682,833
% of Holdings
10.6%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
20,425
Price
$66.16
Total Value
$1.35M
Shares Held After
8,977
% of Holdings
69.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
54,575
Price
$65.37
Total Value
$3.57M
Shares Held After
29,402
% of Holdings
65.0%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
9,821
Price
$2.70
Total Value
$26.52K
Shares Held After
62,586
% of Holdings
13.6%
NEUROCRINE BIOSCIENCES INC (NBIX)
Onyia Jude — Chief Scientific Officer
Shares
11,000
Price
$155.53
Total Value
$1.71M
Shares Held After
25,846
% of Holdings
29.9%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting & Technology Officer
Shares
5,000
Price
$65.00
Total Value
$325.00K
Shares Held After
6,230
% of Holdings
44.5%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
15,000
Price
$8.25
Total Value
$123.79K
Shares Held After
5,100,215
% of Holdings
0.3%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
1,500
Price
$8.25
Total Value
$12.38K
Shares Held After
5,115,215
% of Holdings
0.0%
InspireMD, Inc. (NSPR)
Stuka Paul — Director
Shares
20,000
Price
$0.88
Total Value
$17.50K
Shares Held After
667,871
% of Holdings
3.0%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
33,800
Price
$26.78
Total Value
$905.22K
Shares Held After
229,918
% of Holdings
12.8%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
5,529
% of Holdings
36.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
97,279
Price
$46.89
Total Value
$4.56M
Shares Held After
15,523,469
% of Holdings
0.6%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
35,721
Price
$46.17
Total Value
$1.65M
Shares Held After
15,620,748
% of Holdings
0.2%
Showing 151–200 of 1900 transactions (page 4 of 38)